The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...

Vertical integration for CDMOs in manufacturing ADCs offers an opportunity to reduce costs and create a more resilient supply ...

Bluejay estimates its current antibody inventory is sufficient to support production of more than nine million Symphony cartridges. The company developed polyclonal antibodies using both third-party ...

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Could the power of positive thinking be enough to boost your immune system? According to a recent study, the answer may be ...

Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products.

The mechanism underlying how seasonal allergies recur year after year with precise timing remains largely unknown. An international team led by Professor Rudolf Valenta has identified a specific type ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Samsung Biologics expands Korea CRDMO lead with MCB and vector services Samsung Biologics widens CRDMO edge with new MCB and ...

Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...

Canadian researchers say a blood test measuring immune response to gut bacteria could help predict Crohn’s disease years ...

Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing ...